Indefinite Delivery Contract SPE2DR25D9130

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract is a single-award, indefinite delivery contract valued at up to $4,999,999 with DMS Pharmaceutical Group Inc., a woman-owned small business. The contract aims to establish multiple regional Prime Vendor Contracts to provide worldwide pharmaceutical support, including branded, generic,...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract aims to establish prime vendor contracts to provide worldwide...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military...
The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The purpose is to establish multiple prime vendor contracts to provide worldwide pharmaceutical support, including branded, generic, and specialty pharmaceuticals, as well as related medical supplies, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other designated...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
The federal contract IDV award is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts, which the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain plans to issue. The purpose is to establish prime vendor contracts to provide worldwide pharmaceutical support, including brand, generic, and specialty pharmaceuticals, as well as pharmaceutical-related products, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides a vehicle for the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contracted products include branded and...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC, which runs through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...

The federal contract IDV award is for a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The single-award indefinite delivery contract has a ceiling value of $4,999,999.00 and is held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler.

The contract covers a wide range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. It is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet, including the Hospital Ships USNS Mercy and USNS Comfort. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion across multiple regional awards. The contract is structured as a firm fixed-price, requirements-type contract with the intention to make multiple awards for separate regions to ensure resiliency in the pharmaceutical supply chain.

Generated 6/6/25, 9:59 AM